SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Trident Lifeline informs about outcome of board meeting

01 Jul 2025 Evaluate
Trident Lifeline has informed about allotment of total 9,94,200 (Nine Lakh Ninety-Four Thousand Two Hundred Only) Fully Convertible Warrants each convertible into or exchangeable for 1(One) fully paid-up equity shares of the Company having face value of Rs. 10 each at a Price (including the warrant subscription price and the warrant exercise price) of Rs. 266 (Rupees Two Hundred Sixty Six Only) each payable in cash (Warrants issue Price) on preferential basis to Promoter/NonPromoter upon receipt of 25% of issue price from the allottees (warrant holders), in accordance with the provisions of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. Pursuant to the provisions of Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, the warrant holders had already paid 25% (Rs. 66.50/- per warrant) of the issue price of the warrant as the warrant subscription price. The balance 75% (Rs.199.50/- per warrant) of the issue price of warrants was to be paid at the time of exercise of option to apply for fully paid –up Equity shares of Rs. 10 each of the Company, against each such warrants held by the warrant holder. In view of above and upon receipt from warrant holders as mentioned here under, the Board of Directors at its meeting held today, on July 01, 2025 has considered and allotted 93000 Equity Shares of Rs 10 each upon conversion/ exchange of equal number of warrants, as per the detail enclosed.

The above information is a part of company’s filings submitted to BSE.

Trident Lifeline Share Price

248.45 -1.20 (-0.48%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×